PhRMA introduces an online platform connecting patients with discounted pharmaceuticals as the U.S. government pressures drug companies to reform pricing and distribution.

The federal government starts a 6-year AI-assisted prior authorization pilot in Washington and five other states to improve Medicare coverage decisions for costly procedures.

The looming deadline for drugmakers to comply with the Most Favored Nation drug pricing policy raises concerns over potential disruptions to Medicare Part D, highlighting regulatory and market risks for U.S. drug pricing and federal entitlement programs.

Medicare Part D sees near-universal prior authorization and rising out-of-pocket costs for GLP-1 drugs in 2025, reflecting insurer adjustments to new cost and regulatory pressures.

The Trump administration's $100,000 H-1B visa fee poses challenges for the healthcare workforce, especially in rural areas, amid hospital closures, regulatory penalties, and healthcare market shifts.

Senate Democrats utilize filibuster to block Republican stopgap funding bill, heightening risk of US government shutdown due to Obamacare subsidy extension dispute and budget negotiations.

The Patients Over Profits Act aims to prohibit ownership of both health plans and providers to curb vertical integration in Medicare-related markets, impacting major payviders like UnitedHealth Group and influencing U.S. healthcare market competition and regulatory enforcement.

Advertising campaigns targeting GOP lawmakers adopt strategic messaging to support extending Obamacare's enhanced premium tax credits, highlighting political stakes and legislative challenges ahead of year-end expiration.

Medicare to pilot AI-driven preauthorization program in six states as federal budget cuts threaten program funding and patient access.

Michigan Democrats use government funding deadline to push for permanent extension of ACA insurance subsidies to avoid premium spikes.